Loading...

Lyme And Chikungunya Vaccines Will Capitalize On Rising Global Mobility

Published
31 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
83.8%
7D
-2.5%

Author's Valuation

€9.560.3% undervalued intrinsic discount

AnalystHighTarget Fair Value